EU Clears Celgene's Abraxane To Treat Pancreatic Cancer
Drugmaker Celgene Corp. said Tuesday that European regulators have greenlighted a mixture involving its drug Abraxane as a new treatment for pancreatic cancer....To view the full article, register now.
Already a subscriber? Click here to view full article